Key terms
About CLPT
Clearpoint Neuro, Inc. engages in the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain and heart. The firm conducts its procedures under direct, intra-procedural magnetic resonance imaging guidance. Its product platform consists of the ClearPoint system and ClearTrace system. The company was founded by Paul A. Bottomley on March 12, 1998 and is headquartered in Solana Beach, CA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest CLPT news
Mar 19
9:00am ET
Wall Street Analysts Are Bullish on Top Healthcare Picks
Mar 19
8:18am ET
ClearPoint congratulates partner PTC Therapeutics on completion of its BLA
Mar 13
9:18am ET
ClearPoint Neuro price target raised to $9 from $8 at Stifel
Mar 13
2:20am ET
Wall Street Analysts Are Bullish on Top Healthcare Picks
Mar 12
4:32pm ET
ClearPoint Neuro reports Q4 revenue $6.8M, consensus $6.53M
Mar 12
4:25pm ET
ClearPoint Neuro Unveils Insightful Investor Presentation Update
Mar 11
8:56am ET
Lake Street Sticks to Their Buy Rating for ClearPoint Neuro (CLPT)
Mar 11
8:06am ET
ClearPoint Neuro announces publication on Prism Neuro Laser Therapy System
Mar 05
9:00am ET
Analysts Are Bullish on These Healthcare Stocks: Achieve Life Sciences (ACHV), ClearPoint Neuro (CLPT)
Feb 29
8:11am ET
ClearPoint Neuro 2.31M share Spot Secondary priced at $6.50
Feb 28
4:46pm ET
ClearPoint Neuro announces offering of common stock, no amount given
Feb 22
5:30pm ET
Analysts Are Bullish on These Healthcare Stocks: ClearPoint Neuro (CLPT), Apollo Medical Holdings (AMEH)
Feb 22
1:45am ET
ClearPoint Neuro’s Strategic Growth and Regulatory Milestones Bolster Buy Rating
Feb 21
4:27pm ET
ClearPoint Neuro announces FDA clearance for ClearPoint 2.2 Software
Jan 23
8:50am ET
Analysts’ Top Healthcare Picks: ClearPoint Neuro (CLPT), Semler Scientific (SMLR)
Jan 22
4:10pm ET
EU MDR certifies ClearPoint Neuro manual SmartTwist Hand Drill and MR Drill Kit
Jan 09
12:45pm ET
ClearPoint Neuro: A Strong Buy on Stellar Financials and Strategic Expansion
Jan 09
7:36am ET
Stifel Nicolaus Remains a Buy on ClearPoint Neuro (CLPT)
Jan 08
4:32pm ET
ClearPoint Neuro sees FDA clearance and launch SmartFrame OR in 2024
Jan 08
4:29pm ET
ClearPoint Neuro sees FY24 revenue $28M-$32M, consensus $30.43M
Jan 08
4:29pm ET
ClearPoint Neuro seesFY24 revenue $28M-$32M, consensus $30.4M
Jan 08
4:28pm ET
ClearPoint Neuro sees FY23 revenue $24M, consensus $23.37M
Jan 08
4:27pm ET
ClearPoint Neuro raises Q4 revenue view to $6.8M from $6.22M, consensus $6.69M
Jan 08
4:26pm ET
ClearPoint Neuro sees Q4 revenue $6.8M, consensu $6.22M
Jan 08
4:26pm ET
ClearPoint Neuro sees Q4 revenue $6.8M, consensu $6.22M
No recent news articles are available for CLPT
No recent press releases are available for CLPT
CLPT Financials
Key terms
Ad Feedback
CLPT Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
CLPT Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range